Short Summary
Google LLC seeks Director Review of a PTAB decision that instituted review of its eight‑year‑old CDN patent (U.S. Pat. 10,057,322). Sandpiper CDN, LLC argues the Board ignored settled‑expectations doctrine and misapplied discretionary‑denial standards.
Detailed Summary
In Petition IPR2025‑01010, Google LLC requests Director Review of the PTAB’s decision to institute review of its U.S. Patent No. 10,057,322, which covers content‑delivery‑network technology. The Patent Owner, Sandpiper CDN, LLC, contends that the Board failed to consider settled‑expectations doctrine—an eight‑year‑old patent should trigger discretionary denial under 35 U.S.C. § 314(a). It also alleges the Board misapplied the Fintiv factors and incorrectly treated a district‑court “pause” as a stay, rendering the institution decision arbitrary and capricious. The Owner asks the Director to reverse the decision and deny institution, emphasizing consistency with prior PTAB rulings.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Google LLC vs Sandpiper CDN, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Electronics Co., Ltd. et al.vsWilus Institute of Standards and Technology Inc.
The PTAB granted institution for IPR2025-01164, allowing Samsung to proceed against Wilus regarding patent 12004262. The Board found a reasonable likelihood of prevailing.
Merck Sharp & Dohme LLC et al.vsThe Johns Hopkins University
Merck Sharp & Dohme LLC challenged U.S. Patent No. 11,643,462 in the PTAB, arguing that all claims are anticipated under 35 U.S.C. § 102 and rendered obvious under 35 U.S.C. § 103. The petitioner asserts that the MSI-H Study Record discloses the claimed method of treating MSI-H cancer with pembrolizumab, leading to a request for institution based on compelling evidence.
Google LLCvsVirtaMove, Corp.
Board email outlining procedural requirements for Director Review responses in IPR2025-00488 and related cases.
Microsoft Corp.vsVirtaMove, Corp.
Microsoft and VirtaMove settled their inter partes review dispute over Patent 7,784,058. The Board granted the joint motion to terminate, dismissing the petitions and keeping the settlement confidential.
RegenX Science Inc.vsNeXtGen Biologics, Inc.
Bankruptcy court approved a settlement between ISE and Synogen parties, including patent assignments and cash payments, leading to dismissal of related disputes.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.